Add To Cart

Section 4
Schizophrenia Spectrum Disorders OCD

Question 4 | Test | Table of Contents

New York State Office of Mental Health

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email: info@mentalhealthce.com 


- Varley, Christopher K. Overview of DSM-5 Changes. Seattle Childrens, New York State Office of Mental Health, p. 30-33.
Reviewed 2023

Update
Rituximab as an adjunctive treatment for schizophrenia spectrum disorder
or obsessive-compulsive disorder:
Two open-label pilot studies on treatment-resistant patients

- Bejerot, S., Sigra Stein, S., Welin, E., Eklund, D., Hylén, U., & Humble, M. B. (2023). Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients. Journal of psychiatric research, 158, 319–329. https://doi.org/10.1016/j.jpsychires.2022.12.003


Peer-Reviewed Journal Article References:
Kamath, V., Crawford, J., DuBois, S., Nucifora, F. C., Jr., Nestadt, G., Sawa, A., & Schretlen, D. (2019). Contributions of olfactory and neuropsychological assessment to the diagnosis of first-episode schizophrenia. Neuropsychology, 33(2), 203–211.

Lopez, D., & Weisman de Mamani, A. (2020). Family-related risk and protective factors for suicidal ideation in individuals with schizophrenia spectrum disorders. Professional Psychology: Research and Practice. Advance online publication.

Penney, D., El-Baalbaki, G., & Lepage, M. (2021). Exploring the factor structure of the PTSD checklist for DSM–5 in psychotic disorders. Psychological Trauma: Theory, Research, Practice, and Policy. Advance online publication.

QUESTION 4
What are the positive symptoms an individual must have for a diagnosis of schizophrenia in DSM-5? To select and enter your answer go to Test
.